Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension.: EETs, Vascular Function, and Hypertension

Abstract : BACKGROUND: We sought to clarify, using functional and biological approaches, the role of epoxyeicosatrienoic acids, nitric oxide (NO)/reactive oxygen species balance, and endothelin-1 in conduit artery endothelial dysfunction during essential hypertension. METHODS AND RESULTS: Radial artery diameter and mean wall shear stress were determined in 28 untreated patients with essential hypertension and 30 normotensive control subjects during endothelium-dependent flow-mediated dilatation induced by hand skin heating. The role of epoxyeicosatrienoic acids and NO was assessed with the brachial infusion of inhibitors of cytochrome P450 epoxygenases (fluconazole) and NO synthase (N(G)-monomethyl-l-arginine [L-NMMA]). Compared with controls, hypertensive patients exhibited a decreased flow-mediated dilatation in response to postischemic hyperemia as well as to heating, as shown by the lesser slope of their diameter-shear stress relationship. In controls, heating-induced flow-mediated dilatation was reduced by fluconazole, L-NMMA, and, to a larger extent, by L-NMMA+fluconazole. In patients, flow-mediated dilatation was not affected by fluconazole and was reduced by L-NMMA and L-NMMA+fluconazole to a lesser extent than in controls. Furthermore, local plasma epoxyeicosatrienoic acids increased during heating in controls (an effect diminished by fluconazole) but not in patients. Plasma nitrite, an indicator of NO availability, increased during heating in controls (an effect abolished by L-NMMA) and, to a lesser extent, in patients, whereas, inversely, reactive oxygen species increased more in patients (an effect diminished by L-NMMA). Plasma endothelin-1 decreased during heating in controls but not in patients. CONCLUSIONS: These results show that an impaired role of epoxyeicosatrienoic acids contributes, together with an alteration in NO/reactive oxygen species balance and endothelin-1 pathway, to conduit artery endothelial dysfunction in essential hypertension. CLINICAL TRIAL REGISTRATION: https://www.eudract.ema.europa.eu. Unique identifier: RCB2007-A001-10-53.
Type de document :
Article dans une revue
Circulation, American Heart Association, 2012, 125 (10), pp.1266-75. 〈10.1161/CIRCULATIONAHA.111.070680〉
Liste complète des métadonnées

Littérature citée [34 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00680446
Contributeur : Robinson Joannides <>
Soumis le : mercredi 19 septembre 2012 - 07:00:28
Dernière modification le : mardi 5 juin 2018 - 10:14:42
Document(s) archivé(s) le : jeudi 20 décembre 2012 - 02:30:09

Fichier

Bellien_et_al-Circulation-2012...
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Citation

Jeremy Bellien, Michele Iacob, Isabelle Remy-Jouet, Daniele Lucas, Christelle Monteil, et al.. Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension.: EETs, Vascular Function, and Hypertension. Circulation, American Heart Association, 2012, 125 (10), pp.1266-75. 〈10.1161/CIRCULATIONAHA.111.070680〉. 〈inserm-00680446〉

Partager

Métriques

Consultations de la notice

455

Téléchargements de fichiers

814